← Bajaj Finserv Mutual Fund

BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH

Equity Data as of Jun 2026 Comparing May 2026 → Jun 2026
Share: WhatsApp X
Stocks Held
33
Jun 2026
Equity Holdings
₹340.38 Cr
Equity only, excl. debt & cash
Top 5 Weight
34.0%
Moderate
Top 10 Weight
58.4%
Moderate
Changes
33
1 new · 1 exits
Top Sector
Pharmaceuticals & Biotechnology
66.3% of portfolio
📋 What Happened This Month BAJAJ FINSERV HEALTHCARE FUND made 1 new addition and exited 1 stock this month. The biggest new buy was Turtlemint Fintech Solutions Limited (Financial Technology (Fintech)) at 1.00% weight. ICICI Prudential Life Insurance Company Limited was the biggest exit (Insurance), which was held at 0.91%. Among existing holdings, Rubicon Research Limited saw the biggest increase — now at 6.02% of the portfolio. Divi's Laboratories Limited was trimmed the most, now at 8.40%. Divi's Laboratories Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 66.3%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Apr 2026 May 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 68.0% 65.7% -2.3%
Healthcare Services 13.6% 19.0% +5.4%
Food Products 2.6% 2.7% +0.1%
Industrial Products 0.5% 2.2% +1.8%
Chemicals & Petrochemicals 0.5% 2.1% +1.7%
Insurance 1.1% 2.0% +1.0%
Retailing 1.2% 1.4% +0.2%
Aerospace & Defense 0.0% 0.6% +0.6%
Agricultural Food & other Products 1.2% 0.0% -1.2%
Diversified FMCG 2.2% 0.0% -2.2%
May 2026 Jun 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 65.7% 66.3% +0.6%
Healthcare Services 19.0% 19.3% +0.2%
Food Products 2.7% 2.8% +0.2%
Chemicals & Petrochemicals 2.1% 2.2% +0.0%
Industrial Products 2.2% 2.0% -0.2%
Retailing 1.4% 1.2% -0.2%
Insurance 2.0% 1.0% -1.0%
Financial Technology (Fintech) 0.0% 1.0% +1.0%
Aerospace & Defense 0.6% 0.3% -0.3%
🟢
Biggest New Buy
Turtlemint Fintech Solutions Limited
1.00% weight · Financial Technology (Fintech)
🔴
Biggest Exit
ICICI Prudential Life Insurance Company Limited
0.91% was held · Insurance
Biggest Add
Rubicon Research Limited
+1.50% · now 6.02%
Biggest Trim
Divi's Laboratories Limited
-0.67% · now 8.40%
🤝 Other funds also bought this month
Turtlemint Fintech Solutions Limited 14 funds
Turtlemint Fintech Solutions Limited
Edelweiss Recently Listed IPO Fund Direct Plan Growth
ITI Value Fund - Direct Plan - Growth Option
ITI Business Cycle Fund- Direct Plan- Growth + more
👋 Other funds also exited
ICICI Prudential Life Insurance Company Limited 3 funds
ICICI Prudential Life Insurance Company Limited
Baroda BNP Paribas Health and Wellness Fund Direct Growth
Motilal Oswal Nifty 50 Index Fund - Direct plan - Growth
ICICI Prudential Balanced Advantage Fund - Direct Plan - Growth

What Changed in the Portfolio This Month?

Comparing May 2026 → Jun 2026

May 2026 Jun 2026
🟢 1 New Entry 🔴 1 Exit ↑ 12 Increased ↓ 19 Decreased
#StockSectorWeight (Jun 2026)
1
Turtlemint Fintech Solutions Limited
₹3.55 Cr
Financial Technology (Fintech) 1.00%
#StockSectorLast Weight (May 2026)
1
ICICI Prudential Life Insurance Company Limited
₹3.02 Cr
Insurance 0.91%
#StockSectorMay 2026Jun 2026Change
1
Rubicon Research Limited
₹21.32 Cr
Pharmaceuticals & Biotechnology 4.52% 6.02% +1.50%
2
Max Healthcare Institute Limited
₹14.72 Cr
Healthcare Services 3.68% 4.16% +0.48%
3
Aurobindo Pharma Limited
₹23.07 Cr
Pharmaceuticals & Biotechnology 6.17% 6.52% +0.35%
4
Senores Pharmaceuticals Ltd
₹8.11 Cr
Pharmaceuticals & Biotechnology 2.05% 2.29% +0.24%
5
Neuland Laboratories Limited
₹16.24 Cr
Pharmaceuticals & Biotechnology 4.39% 4.59% +0.20%
6
Emcure Pharmaceuticals Limited
₹15.43 Cr
Pharmaceuticals & Biotechnology 4.18% 4.36% +0.18%
7
Zydus Wellness Limited
₹9.98 Cr
Food Products 2.65% 2.82% +0.17%
8
IPCA Laboratories Limited
₹8.59 Cr
Pharmaceuticals & Biotechnology 2.31% 2.43% +0.12%
9
Laurus Labs Limited
₹7.59 Cr
Pharmaceuticals & Biotechnology 2.05% 2.14% +0.09%
10
GlaxoSmithKline Pharmaceuticals Limited
₹5.83 Cr
Pharmaceuticals & Biotechnology 1.58% 1.65% +0.07%
#StockSectorMay 2026Jun 2026Change
1
Divi's Laboratories Limited
₹29.75 Cr
Pharmaceuticals & Biotechnology 9.07% 8.40% -0.67%
2
Piramal Pharma Limited
₹21.38 Cr
Pharmaceuticals & Biotechnology 6.51% 6.04% -0.47%
3
MTAR Technologies Limited
₹1.14 Cr
Aerospace & Defense 0.59% 0.32% -0.27%
4
MedPlus Health Services Limited
₹4.19 Cr
Retailing 1.39% 1.18% -0.21%
5
Shaily Engineering Plastics Ltd
₹7.18 Cr
Industrial Products 2.23% 2.03% -0.20%
6
Sun Pharmaceutical Industries Limited
₹22.50 Cr
Pharmaceuticals & Biotechnology 6.54% 6.36% -0.18%
7
Glenmark Pharmaceuticals Limited
₹6.12 Cr
Pharmaceuticals & Biotechnology 1.90% 1.73% -0.17%
8
Abbott India Limited
₹4.42 Cr
Pharmaceuticals & Biotechnology 1.40% 1.25% -0.15%
9
Biocon Limited
₹4.79 Cr
Pharmaceuticals & Biotechnology 1.48% 1.35% -0.13%
10
Fortis Healthcare Limited
₹11.50 Cr
Healthcare Services 3.36% 3.25% -0.11%

What Stocks Does This Fund Hold?

33 stocks — Jun 2026

# Stock Sector Cap Weight & Value
1
₹29.75 Cr
Pharmaceuticals & Biotechnology
8.40%
2
₹23.75 Cr
Healthcare Services
6.71%
3
₹23.07 Cr
Pharmaceuticals & Biotechnology
6.52%
4
₹22.50 Cr
Pharmaceuticals & Biotechnology
6.36%
5
₹21.38 Cr
Pharmaceuticals & Biotechnology
6.04%
6
₹21.32 Cr
Pharmaceuticals & Biotechnology
6.02%
7
₹18.63 Cr
Pharmaceuticals & Biotechnology
5.26%
8
₹16.24 Cr
Pharmaceuticals & Biotechnology
4.59%
9
₹15.43 Cr
Pharmaceuticals & Biotechnology
4.36%
10
₹14.72 Cr
Healthcare Services
4.16%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 Bajaj Finserv Mutual Fund — Portfolio & Holdings
See all funds managed by Bajaj Finserv Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.